Evaluation of Medication Management Service
Recruiting now · Not applicable
Conditions studied: Medication Adherence, Medication Safety, Diabetes Mellitus, Type 2, Hypertension, Polypharmacy, High Risk Medications
In brief
Medication management services (MMS) is a pharmacist-led service of optimizing the medication use and health outcomes, by promoting medication safety and enhancing the ability in self-management of health and diseases of patients and their caregivers. Yet, only limited evidence on the implementation of MMS service in Hong Kong is available. The goal of this clinical trial is to evaluate the cost effectiveness and effects of implementing MMS in community pharmacies owned by 8 non-government organizations (NGOs) in Hong Kong on humanistic and clinical outcomes in patients with hypertension and/or type II diabetes mellitus. The clinical trial aims to look into the following aspects: * To evaluate the perception and satisfaction of patients on MMS service * To investigate whether MMS could improve patients' adherence to their medication regimen, health-related quality of life, health outcomes and health service utilization, as well as their ability to understand and cope with their illness and drug-related problems * To identify and categorize the types of drug-related problems identified during MMS * To evaluate the cost-effectiveness of implementing MMS in community pharmacies MMS services will be rolled out in a total of 8 NGO community pharmacies progressively (2 pharmacies per phase) in 4 successive phases. Participants will complete the questionnaires at the following time points throughout the trial, namely 1) during recruitment, 2) baseline (1 month before MMS), 3) 3 months after MMS begins, 4) 12 months after MMS begins, and 5) 24 months after MMS begins. Researchers will compare the results of questionnaires conducted at different time points to identify the potential changes in the effects of MMS. Furthermore, researchers will link up the electronic health records of the participants and identify the potential changes in the health outcomes and health service utilizations after receiving MMS.
Key facts
- Study ID
- NCT06273761
- Run by
- The University of Hong Kong
- People needed
- 640
- Starts
- 2024-02-06
- Expected to finish
- 2027-05-01
- Last updated by the study team
- 2024-02-23
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- aged 18 years or above
- diagnosed with Type 2 diabetes mellitus and/or hypertension
- having regular follow-up on Type 2 diabetes mellitus and/or hypertension at Hospital Authority
- no A\&E admission/hospitalization in the past 3 months
- no recent changes in medication regimen in the past 3 months
- polypharmacy (taking 5 or more chronic medications)
- using at least 1 high-risk medication (Anticoagulants, Oral hypoglycaemics, Insulins, psychotropic medications or immunosuppressants)
- able to communicate in Cantonese and/or English
You may not qualify if…
- aged below 18
- unable to give informed consent
- unable to communicate in Cantonese and/or English
Where it is running
- Aberdeen Kai-Fong Welfare Association A-Lively Community Pharmacy — Hong Kong, Hong Kong (enrolling)
- Health In Action Community Pharmacy — Hong Kong, Hong Kong (enrolling)
- Hong Kong Sheng Kung Hui Welfare Council Community Pharmacy — Hong Kong, Hong Kong (enrolling)
- PHARM+ Haven of Hope Community Pharmacy — Hong Kong, Hong Kong (enrolling)
- PHARM+ Pok Oi Hospital Community Pharmacy — Hong Kong, Hong Kong (enrolling)
- PHARM+ St. James' Settlement Community Pharmacy — Hong Kong, Hong Kong (enrolling)
- PHARM+ The Lok Sin Tong Community Pharmacy — Hong Kong, Hong Kong (enrolling)
- PHARM+ YWCA Community Pharmacy — Hong Kong, Hong Kong (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.